Here, we found that the beneficial effects of combination treatment on counteracting AD-like pathology in APP/PS1 mice were concurrent with its anti-inflammatory effects and microglial transformation into functional microglia, leading to enhanced microglial Aβ clearance. Here, APP is linked to Alzheimer disease.